David P Bray

Dr. David P Bray


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2020 in Neurosurgery
Verified
Journal Article
Open access
PDF file
DBDavid P Bray
David P Bray
GSGeoffrey P Stricsek
Geoffrey P Stricsek
JMJames Malcolm
James Malcolm
JGJuanmarco Gutierrez
Juanmarco Gutierrez
AGAlexander Greven
Alexander Greven
DRDaniel Refai
Daniel Refai

4 August 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
DBDavid P Bray
David P Bray
SMSai Mannam
Sai Mannam
RRRima S. Rindler
Rima S. Rindler
JQJoseph W. Quillin
Joseph W. Quillin
NONelson M. Oyesiku
Nelson M. Oyesiku
Acromegaly is a disease that occurs secondary to high levels of GH, most often from a hormone-secreting pituitary adenoma, with multisystem adverse effects. Diagnosis includes serum GH and IGF-1 levels, and obtaining an MRI pituitary protocol to assess for a functional pituitary adenoma. Attempted gross total resection of the GH-secreting adenoma is the gold standard in treatment for patients with acromegaly for a goal of biochemical remission. Medical and radiation therapies are available when patients do not achieve biochemical cure after surgical therapy.

13 February 2021 in Neurosurgery
Verified
Journal Article
Closed access
DBDavid P Bray
David P Bray
JQJoseph W Quillin
Joseph W Quillin
RPRobert H Press
Robert H Press
YYYilin Yang
Yilin Yang
ZCZhengjia Chen
Zhengjia Chen
JOJeffrey J Olson
Jeffrey J Olson
BACKGROUND: Atypical meningiomas (AMs) are meningiomas that have a higher rate of recurrence than grade I meningioma. Due to the higher risk of recurrence, adjuvant radiotherapy (RT) after resection of AM has been employed. At our institution, some neurosurgeons employ adjuvant RT on all primarily resected AMs, while others employ watchful waiting with serial imaging. OBJECTIVE: To study the effect of adjuvant RT on newly resected AMs. METHODS: A retrospective review of all AMs primarily resected at our institution from 1996 to 2018 was completed. Data on patient demographics, radiographic findings, use of adjuvant RT, time of follow-up, and recurrences were collected. Adjuvant RT was defined as RT that occurred within 6 mo of initial resection. RESULTS: A total of 162 patients met the inclusion criteria. Gross total resection was achieved in 73% of cases. Average time until recurrence in the cohort was 37 mo. A total of 108 patients had adjuvant RT, while 54 patients did not. On multivariate survival analysis, sex, Simpson grade resection, and use of adjuvant RT were independent predictors of recurrence. Mean time to recurrence in patients who received adjuvant RT was 43.7 mo versus 34.7 mo for those who did not receive adjuvant RT. CONCLUSION: This study includes the largest retrospective cohort of patients who have received adjuvant RT after primary resection of AM. Our results suggest that the use of adjuvant RT is independently associated with a lower chance of recurrence. These data suggest that practitioners can consider the use of adjuvant RT for newly resected AMs, regardless of Simpson grade resection.

1 February 2021 in World Neurosurgery
Verified
Journal Article
Closed access
DBDavid P Bray
David P Bray
CSC. Arturo Solares
C. Arturo Solares
NONelson M. Oyesiku
Nelson M. Oyesiku

4 June 2024 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
DBDavid P Bray
David P Bray
NSNolan M. Stubbs
Nolan M. Stubbs
JCJocelyn Chow
Jocelyn Chow
AJArman Jahangiri
Arman Jahangiri
ENEdjah K. Nduom
Edjah K. Nduom
KHKimberly B. Hoang
Kimberly B. Hoang

1 June 2020 in World Neurosurgery
Verified
Journal Article
Closed access
DBDavid P Bray
David P Bray
CRChristopher W. Rich
Christopher W. Rich
JEJason A. Ellis
Jason A. Ellis
GPGustavo Pradilla
Gustavo Pradilla
DBDaniel Barrow
Daniel Barrow